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The complete amino acid sequence of prostaglandin endoperoxide synthase from sheep vesicular gland has been deduced 
by cloning and sequence analysis of DNA complementary to its messenger RNA. The results were confirmed by digestion 
of the enzyme with carboxypeptidase Y and by automated Edman degradation of the intact enzyme polypeptide and 
peptide fragments obtained by limited proteolysis of the enzyme with Achromobacfer p oteinase I. Mature sheep prosta- 
glandin endoperoxide synthase is shown to be composed of 576 amino acids with an M, of 66 175. The precursor peptide 
is predicted to contain a 24-residue signal peptide. The serine residue susceptible to acetylation by aspirin is found to 
be located near the C-terminus of the enzyme polypeptide. 
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1. INTRODUCTION 
Prostaglandins (PC&) and thromboxane are po- 
tent biological mediators. The initial step of their 
biosyntheses is catalyzed by PG endoperoxide syn- 
thase. The enzyme has been purified from bovine 
[l] and sheep vesicular gland [2,3]. The enzyme is 
a membrane-bound glycoprotein with an kf, of 
67000-72000 and exhibits both activities of fatty 
acid cyclooxygenase (arachidonic acid - PGG$ 
and PG hydroperoxidase (PGG2 --+ PGH2) 
[l-3]. Aspirin inhibits the cyclooxygenase activity 
by acetylating a single serine residue of the en- 
zyme. The peptic fragment of the enzyme contain- 
ing the acetylated serine residue was isolated from 
the enzyme inactivated by aspirin and the amino 
acid sequence was determined [4,5]. In order to 
elucidate the reaction mechanism of the enzyme it 
is important to determine its primary structure. 
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The nucleotide sequence presented here has been submitted to 
the EMBL/GenBank database under the accession number 
YOO750 
Here, we describe the cloning of cDNA encoding 
PG endoperoxide synthase from sheep vesicular 
gland and the complete amino acid sequence of the 
enzyme deduced from the cDNA sequence. 
2. MATERIALS AND METHODS 
Partially purified PC endoperoxide synthase was prepared 
from sheep vesicular glands using DEAE-Cellulofine (Chisso, 
Tokyo) as described in [1,2], and subjected to preparative 7% 
SDS-polyacrylamide gel electrophoresis for further purification 
[6]. The purified enzyme (1OOpg) which was pyridylethylated 
according to [7] was incubated with 5 pg Achromobacter pro- 
teinase I in 50 mM Tris-HCl buffer, pH 8.0, containing 0.5% 
SDS and 1 mM EDTA at 37°C for 12 h. The polypeptide 
fragments were separated by reverse-phase high-performance li- 
quid chromatography with a O-50% linear gradient of 
acetonitrile in 0.1% trifluoroacetic acid as described (81. The C- 
terminal amino acid of the enzyme was determined by digesting 
it with carboxypeptidase Y according to [9]. The amino acid se- 
quence and amino acid analyses were carried out as described 
in [8]. 
Total and poly(A)+ RNAs were prepared from sheep vascular 
glands as described in [lo]. 24- and 21-mer oligonucleotides, 
5 ’ -~TATTCIGG~CTT$IATIGG~TT-3 ’ (oligonucleotide 1, 1 
denotes inosine) and 5 ‘-A~AIGGIGCICCCATT$A~T-3 ’ 
(oligonucleotide 2) were synthesized on the basis of the C- and 
N-terminal portions (in one-letter code, NPIESPEY and 
IEMGAPF, respectively) of the amino acid sequence of the 
aspirin-acetylation site [5]. cDNA libraries were constructed 
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Fig.1. Restriction map and sequencing strategy for the cDNA 
clones. The restriction map shows only the relevant restriction 
sites, which are identified by numbers indicating the 5’-terminal 
nucleotide generated by cleavage. The poly(dA) . poly(dT) tract 
and poly(dG) . poly(dC) tails are not included in the restriction 
map. The protein coding region is indicated by a closed box, the 
regions used for synthesis of oligonucleotides by open boxes. 
The direction and extent of sequencing are illustrated by 
horizontal arrows under each clone used. 
with oligo(dT)tz-is or synthetic oligonucleotides as a primer us- 
ing poly(A)’ RNA from sheep vesicular glands as a template ac- 
cording to [ll]. Transformation and screening procedures were 
as in [12]. Nucleotide sequence was determined by the dideoxy 
chain-termination method [13] as described [14]. RNA blot 
hybridization analysis was carried out according to [15]. 
Hydropathicity analysis using the procedure of Kyte and 
Doolittle [16] and prediction of protein secondary structure by 
Chou-Fasman procedure [17] were performed with the aid of 
the SDC-GENETYX program (Software Development, 
Tokyo). 
3. RESULTS AND DISCUSSION 
The N-terminal amino acid sequence of the 
purified PG endoperoxide synthase from sheep 
vesicular gland was the same as that of the 
previous report [4] (see fig.2). The enzyme 
polypeptide was also digested with Achromobacter 
proteinase I and the fragments were examined for 
amino acid sequence (see fig.2). 
A cDNA library was constructed using poly(A)+ 
RNA from sheep vesicular glands as a template 
and the oligonucleotide 1 as a primer. Screening of 
about 2 x lo5 transformants from the cDNA 
library with the oligonucleotide 2 led to the selec- 
tion of 3 positive clones including pPESl1 (fig. 1). 
Inserts of these clones contained the same 
nucleotide sequence. Using pPESl1 as a probe for 
cloning longer cDNA sequences, clones pPES28, 
pPES31, pPES33, pPES40 and pPES43 were ob- 
tained from the oligo(dT)- and oligonucleotide 
l-primed cDNA libraries. For isolation of clones 
containing the 5 ‘-terminal region of cDNA, a syn- 
thetic oligonucleotide, 5 ’ -AGTATAATAGCTCA- 
CAT-3 ’ , complementary to the nucleotide se- 
quence 359-375 was prepared and elongated using 
poly(A)+ RNA from sheep vesicular glands as a 
template. Screening of 1 X lo4 transformants from 
the primer-extension library with the 5’-terminal 
Sau3AI fragment of pPES43 insert yielded two 
clones, pPES102 and pPES103. DNA sequencing 
was performed on the inserts of 8 cDNA clones 
(fig. l), which covered a 2611-nucleotide sequence 
of cDNA for PG endoperoxide synthase from 
sheep vesicular gland. 
Fig.2. Nucleotide sequence of cloned cDNA for sheep vesicular gland prostaglandin endoperoxide synthase and deduced amino acid 
sequence of the protein. Nucleotide residues are numbered beginning with the first residue of the GCG codon encoding the alanine 
of the N-terminus. The deduced amino acid sequence is shown below the nucleotide sequence and amino acid residues are numbered 
beginning with the N-terminal alanine. Fine underlining indicates amino acid sequences determined by Edman degradation. 
Ambiguously identified residues within a sequenced peptide are indicated by a dotted line. Broken underlining indicates C-terminal 
residues determined by carboxypeptidase Y digestion. The serine residue susceptible to acetylation by aspirin and the amino acid 
sequence of the peptic peptide containing the serine residue are indicated by an asterisk and thick underlining, respectively 151. The 
potential asparagine-linked glycosylation sites are indicated by arrowheads. The nucleotide differences observed among the individual 
clones are as follows: G (pPESlO2 and 103) or A (pPES43) at nucleotide residues 3 and 218; C (pPES102 and 103) or A (pPES43) 
at 9; G (pPES103 and 43) or A (pPES102) at 165; A (pPES40) or G (pPES43) at 419; A (pPES40) or G (pPES31) at 819; G (pPES40) 
or A (pPES31) at 846; G (pPES33 and 28) or A (pPES31) at 1188; G (pPES33 and 31) or A (pPES28) at 1295; A (pPES33) or 0 
(pPES31 and 28) at 1302; G (pPES33 and 31), A (pPES28) or C (pPESl1) at 1486; G (pPES33, 28, and 11) or A (pPES31) at 1488; 
G (pPES33, 31 and 11) or A (pPES28) at 1503 and 1506; A (pPES33) or G (pPES28) at 1674; G (pPES33) or A (pPES28) at 1799 
and 2028. The resulting amino acid substitutions are as follows: Arg or His at amino acid residue 73; Asp or Gly at 140; Arg or Gin 
at 432; Glu, Gin or Lys at 496; Met or Ile at 501. Wherever a nucleotide or amino acid difference occurs, the first named residue is 
shown in the sequences presented. 
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5'----CCTGAGTCGGTCTCCAGCACG -91 
C~cGGccAcccTGcAccATGAGccGGCAGAGTATCTCGCTCCGATTCCCGCTGCTTCTCCTGCTGcTGTcGccATcccccGTcTTcTcA -1 
~e~S~rA~gGlnSerIleS~rLeuAr~PheProLeuLeuLe"Le"Le"Le"Se~PrOS~rPrOV~lPh~S~r -1 
GcGGAccccGGGGcGcccGcGcCAGTCAACCCCTGCTGTTACTATCCATGCCAGCACCAGGGGATCTGTGTTcGcTTcGGccTTGAccGc 90 
AlaAspproGlyAl~P~~AlaProValAsnPra~~~~~~~Ty~TyrProCysGlnHisGlnGlyIleCysValArgPheGlyLe"A~PA~g 30 
TAcc~TGTGACTGcAccCGCACGGGCTATTCCGGCCCCAACTGCACCATCCCGGAGATATGGACCTGGcTccGGAcGAcTTTGcGGccc 180 
TyrGlncy~A~pCysThrArgThrGlyTyrSerGlyProAsnCysThrIleP~oGluIleT~pThrTrpLe"A~~ThrThrLe"Ar~PrO 60 
A 
AGCcccTcTTTcATCcACTTTcTGCTGACGCACGGGCGCTGGCTTTGGGATTTTGTC~TGCCACCTTCATccGGGAcAcGcTcATGcGT 270 
SerProSerPheIleHisPheLeuLe"ThrHisGlyArgTrpLeuTrpAspPheValA~nAl~Th~PheIl~ArgA~pThrL~"~~~Ar~ 90 
i 
cTGGTAcTcACAGTGCGTTCCAACCTTATCCCCAGCCCTCCCACCTACAACATAGCGCACGATTACATCAGcTGGGAGTccTTcTcc~T 360 
Le"valLeuThrValArgSerAsnLe"IleProSerProProThrTyrAsnIleAlaHisAspTyrIleSerTrpGl"SerPheSerAs" 120 
A 
GTGAGCTATTATACTCGCATTCTGCCCTCCGTGCCCCGAGACTGTCCCACGCCCATGGACACCAAAGGGAACAAGCAATTGCCAGATGCG 450 
ValSerTyrTyrThrArgIleLeuProSerValProAr~AspCysP~oThrProMetAspThrLysGlyLysLysGl"Le"ProAspAla 150 
GAGTTCCTGAGCCGTCGCTTCCTGCTCAGGAGGAAGTTCATCCCTGACCCTC~GCACC~CCTCATGTTTGCCTTCTTTGCCC~CAC 540 
Gl"PheLe"SerArgArgPheLe"LeuAr~Ar~LysPheIleProAspProGln~~rThrAsnLe"MetPheAlaPhePheAlaGl"His 180 
TTCACCCATCAGTTCTTCAAAACTTCCGGCAAGATGGGTCCTGGCTTCACCAAGGCGCTGGGCCACGGGGTAGACCTCGGCCACATTTAT 630 
PheThrHisGlnPhePheLysThrSerGlyLysMetClyProGlyPheThrLysAlaLe"GlyHisGlyValAspLe"GlyHisIleTyr 210 
GGAGACAATCTGGAACGTCAGTATCAGCTCTTTATGGAGAGGTGTACCCGCCA 720 
GlyAspAsnLeuGluAr~GlnTyrGlnLe"Ar~Le"PheLysAspGlyLysLe"LysTyrGl"MetLe"As"GlyGl"ValTyrProPro 240 
TCGGTGGlWGAGGCGCCCGTGCTGATGCACTACCCCCGGGGCATCCCGCCCCAGAGCCAGATGGCTGTGGGCCAGGAGGTGTTTGGGCTG 810 
SerValGluGluAlaProValLeuMetHisTyrProAr~GlyIleProProGlnSerGlnMetAlaValGlyGlnGluValPheGlyLeu 270 
CTTCCTGGACTCATGCTCTACGCCACGATCTGGCTGCGTGAGCACAACCGCGTGTGTGACCTGCTG~GGCTCAGCACCCCACCTGGGGC 900 
Le"ProGlyLeuMetLeuTyrAlaThrIleTrpLeuArgcluHisAsnArgValCysAspLe"LeuLysAlaGluHisProThrTrpGly 300 
GACGAGCAGCTCTTCCAGACGGCCCGCCTCATCCTCATCGGGGAGACCATCAACATTGTCATAGAGGAGTATGTGCAGCAGCTGAGCGGC 990 
AspGluGlnLeuPheGlnThrAlaAr~I~euIleLe"IleGlyGl"ThrIleLysIleValIleGluGl"TyrValGlnGlnLe"SerGly 330 
TACTTCCTGCAGCTCAAGTTCGACCCAGAGCTGCTGTTCGGGGCCCAGTTCCAGTACCGCAACCGCATCGCCATGGAGTTC~CCAGCTG 1080 
TyrPheLeuGlnLeuLysPheAspProGluLe"LeuPheGlyAlaGl"PheGlnTyrAr~AsnAr~IleAlaMetGluPheAsnGlnLeu 360 
TACCACTGGCACCCGCTCATGCCCGACTCCTTCCGGGTGGGCCCCCAGGACTACAGCTACGAGCAGTTTCTGTTC~CACCTCCATGCTG 1170 
TyrHisTrpHisProLeuMetProAspSerPheArgValGlyP~oGlnAspTyrSerTyrGluGlnPheLeuPheAsnThrSerMetLeu 390 
A 
GTGGACTACGGGGTCGAGGCCCTGGTGGACGCCTTTTCTCGCCAGCCTGCAGGCCGGATTGGTGGGGGTAGGAACATAGACCACCACATC 1260 
ValAspTyrGlyValGluAlaLeuValAspAlaPheSerArgGlnProAlaGlyArgIleGlyGlyGlyArgAsnIleAspHisHisIle 420 
CTGCACGTGGCCGTGGATGTCATCAAGGAATCACGGGTGCTGCAGCCCTTCAATGAGTACCGCAAGAGGTTTGGCATGAAGCCC 1350 
LeuHisValAlaValAspValIleLysGl"SerAr~ValLe"Ar~LeuGlnProPheAsnGl"TyrA~~LysAr~PheGlyMe~LysPro 450 
TACACCTCTTTCCAAGAGCTCACAGGTGAGAAGGAGATGGCAGCTGAATTGGAGGAGCTGTATGGAGACATTGATGCTTTGGAATTCTAC 1440 
TyrThrSerPheGl"Gl"Le"ThrGlyGl"LysGl"MetAlaAlaGl"LeuGluGluLe"TyrGlyAspIleAspAlaLe"Gl"PheTyr 480 
CCGGGGCTACTTCTTGAGAAGTGCCATCCGAACTCCATCTCCATCTTTGGGGAGAGTATGATAG~TGGGGGCTCCTTTTTCCCTT~GGGCCTC 1530 
ProGlyLeuLeuLe"GluLysCysHisProAsnSerIlePheGlyGluSerMetIleGl"MetGlyAlaProPhese~Le"Ly~GlyLe" 510 
* 
TTAGG~CCCCATCTGTTCTCCACAGTACTGGAAGGCGAGCACATTTGGCGGTGAGGTGGGCTTC~CCTTCTCAAGACGGCCACGCTA 1620 
Le"GlyAs"ProIleCysSerProGluTyrTrpLysAlaSerThrPheGlyGlyGl"ValGlyPheAsnLeuValLysThrAlaThrL~u 540 
AAGAAGCTGGTTTGCCTCAACACCAAGACTTGTCCCTATGTCTCCTTCCACGTACCAGACCCCCGTCAGGAGGACAGGCCTGGGGTGGAG 1710 
LysLysLeuValCysLeuAsnThrLysThrCysProT~rValSerPheHisValP~oAspProArgGlnGl"AspArgPr~GlyV~lGlu 570 
CGGCCACCCACAGAGCTCTGAAGGGGGCCGGGCAGCATTGCCACGGGGTGGA 1800 
ArgProProThrGluLeu*** 576 __________. 
TTGTCTTTGATGTTGGGTTTCTGATTTGGTGTCGAGAGCATCAGTCTCGACGTTTAGAACTCTACGTCTCTCACCCATGGTCTGC~TA~ 1890 
TGTGTTCCTTGTTTGTTGTTCTAGAATGCTGAATTCCTGGT~ACCATTGAG~TGTTAGGACTCGTTATCCCTTCAGCATGCCAG~CA 1980 
CTGGGTTCCTGGGTGACCACCTAGAATGTCAGATTTCTAGTTGATCCGG~TTTAGGCACTCTG~ATATGGCACTCCTGATGGAATCAT 2070 
CTGGAAAGTGAGGGGGTTTTTATTTTGCATTCTAC~TTCTGGGTGGCCCTCCAG~TGTCGACTTTCTGACTGGTTATCCGG~TGTTG 2160 
TG~TCCGAGTTGCTGATCCACAACACTGGCTGGCATTCTACATCAGTCCTGATCCGAATGTCTAGAGTGTG~AGAATT~ATTTT~~TGTT 2250 
CAGTGAGACAGCCACGGAGCAGGAGGATCTCGTGTCCTACAAG~CGCATTGCCTGGATCTGTGCCTGCATGGAGAGGGCA~G~GTGG 2340 
GGTGTT~GT~TTCTCAGTGGGACCCCTGATGAGACCCTAGATATGGAGAGAACAGGTGGCTTTCTCCAGG~~ATTGGTTGG~G~~A~~A 2430 
CAGcTcTGTCCTCATCCAGGTCTCAACTCACGGCAGCTGTTTTTCATG~GTT~TGCTTTTTcC----3' 2500 
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The nucleotide and deduced amino acid se- 
quence are presented in fig.2. Primary structure of 
sheep PG endoperoxide synthase was deduced 
from the cDNA sequence using the reading frame 
corresponding to the N-terminal amino acid se- 
quence of the intact enzyme polypeptide, the 
amino acid sequences of 6 Achromobacter pro- 
teinase I fragments, and that of the aspirin- 
acetylation site. The deduced amino acid sequence 
presented in fig.2 contains all the amino acid se- 
quences described above except the residue at 516. 
All the nucleotide sequences corresponding to the 
amino acid residue 516 in clones pPES28, pPES31 
and pPES33 were TGT. The alanine residue at 
position 1 is the N-terminus of the enzyme deter- 
mined from the protein [4]. The first ATG 
(nucleotide residues - 72 to - 69) was assigned as 
the translational initiation codon. The nucleotide 
sequence surrounding the putative initiation codon 
agrees with the consensus sequence for eukaryotic 
initiation codons described by [ 181. The nucleotide 
residues - 72 to - 1 encodes a 24-amino acid 
polypeptide which shows a characteristic sequence 
of the signal peptide [ 191. A termination codon 
was found in frame after the 576th codon. A 
typical polyadenylation signal, AATAAA, ap- 
peared at nucleotide residues 2484-2489. 
Although the poly(dA) tract is not shown in fig.2, 
the residue 2500 was followed by (dA)re. Deter- 
mination of the C-terminal amino acid sequence 
with carboxypeptidase Y indicated a sequence of 
Thr-Glu-Leu, which agreed with the amino acid se- 
quence deduced from the nucleotide sequence on 
the 5 ‘-side of the termination codon. Therefore, a 
mature form of the enzyme is composed of 576 
amino acid residues, omitting glycosyl residues, 
with an M, of 66 175. Except tryptophan the amino 
acid composition of the enzyme determined with 
the purified enzyme [20] coincided well with that 
calculated from the deduced amino acid sequence 
(not shown). Total RNA from sheep vesicular 
glands was shown to contain a mRNA species of 
approximately 3300 nucleotides that hybridized to 
the SmaI(758)-SmaI(1443) fragment of pPES31 
(fig.3). 
The enzyme is a glycoprotein and contains 
4-5 mol of N-acetylglucosamine and 12- 16 mol 
of mannose per mol of the enzyme polypeptide [3]. 
Four potential asparagine-linked glycosylation 
sites (residues 44, 80, 120 and 386) were found in 
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Fig.3. Autoradiogram of blot hybridization analysis of sheep 
vesicular gland RNA with a cDNA probe. 10 pg of total RNA 
was analyzed. The size markers used were sheep and 
Escherichiu co/i rRNA [21]. 
the deduced amino acid sequence. Hydropathicity 
profile of the deduced amino acid sequence of the 
enzyme showed several hydrophobic regions in- 
cluding the signal peptide (amino acid residues 
- 19 to -8, 78-95, 261-282, 304-321 and 
383-399). PG endoperoxide synthase is a mem- 
brane protein [l-3] and it has been shown by elec- 
tron microscopic immunocytochemistry that the 
enzyme is associated with the endoplasmic 
reticulum and nuclear membrane in Swiss mouse 
3T3 fibroblasts [22]. Thus, some of these 
hydrophobic segments possibly constitute mem- 
brane spanning portions and/or interact with 
hydrophobic substrates such as arachidonic acid. 
Cyclooxygenase activity of the enzyme is inhibited 
by acetylation with aspirin. The amino acid se- 
quence of the aspirin-acetylation site is present 
near the C-terminus of the enzyme polypeptide: 
the serine residue specifically acetylated by aspirin 
was found to be the residue at 506. The portion 
around the serine residue is hydrophobic and is 
predicted to form an a-helical structure. 
Acknowledgements: This work was supported in part by grants 
from Ministry of Health and Welfare, Ministry of Education of 
Japan and Cardiovascular Research Foundation, Japan. 
REFERENCES 
[l] Miyamoto, T., Ogino, N., Yamamoto, S. and Hayaishi, 
0. (1976) J. Biol. Chem. 251, 2629-2636. 
Volume 231, number 2 FEBS LETTERS April 1988 
[2] Hemler, M., Lands, W.E.M. and Smith, W.L. (1976) J. 
Biol. Chem. 251, 5575-5579. 
[3] Van der Ouderaa, F.J., Buytehek, M., Nugteren, D.H. 
and Van der Dorp, D.A. (1977) Biochim. Biophys. Acta 
487, 315-331. 
[4] Van der Ouderaa, F.J., Buytenhek, M., Nugteren, D.H. 
and Van der Dorp, D.A. (1980) Eur. J. Biochem. 109, 
l-8. 
[5] Roth, G.J., Machuga, E.T. and Ozols, J. (1983) 
Biochemistry 22, 4672-4675. 
[6] Laemmli, U.K. (1970) Nature 227, 680-685. 
[7] Hermodson, M.A., Ericsson, L.E., Neurath, H. and 
Walsh, K.A. (1973) Biochemistry 12, 3146-3153. 
[8] Wada, K., Takai, T. and Tanabe, T. (1987) Eur. J. Bio- 
them. 167, 13-18. 
[9] Botelho, L.H., Ryan, D.E. and Levin, W. (1979) J. Biol. 
Chem. 254, 5635-5640. 
[lo] Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. and 
Rutter, W.J. (1979) Biochemistry 18, 5294-5299. 
[ll] Maniatis, T., Fritsch, E.F. and Sambrook, J. (1982) in: 
Molecular Cloning: A Laboratory Manual, pp.230-241, 
Cold Spring Harbor Laboratory, Cold Spring Harbor, 
NY. 
[12] Takai, T., Noda, M., Furutani, Y., Takahashi, H., 
Notake, M., Shimizu, S., Kayano, T., Tanabe, T., 
Tanaka, K., Hirose, T., Inayama, S. and Numa, S. (1984) 
Eur. J. Biochem. 143, 109-115. 
[13] Sanger, F., Nicklen, S. and Coulson, A.R. (1977) Proc. 
Natl. Acad. Sci. USA 74, 5463-5467. 
[14] Furutani, Y., Notake, M., Fukui, T., Ohue, M., Nomura, 
H., Yamada, M. and Nakamura, S. (1986) Nucleic Acids 
Res. 14, 3167-3179. 
[15] Thomas, P.S. (1980) Proc. Natl. Acad. Sci. USA 77, 
5201-5205. 
[16] Kyte, J. and Doolittle, R.F. (1982) J. Mol. Biol. 157, 
105-132. 
[17] Chou, P.Y. and Fasman, G.D. (1978) Annu. Rev. 
Biochem. 47, 251-276. 
[18] Kozak, M. (1984) Nucleic Acids Res. 12, 857-873. 
[19] Steiner, D.F., Quinn, P.S., Chan, S.J., Marsh, J. and 
Tager, H.S. (1980) Ann. NY Acad. Sci. 343, l-16. 
[20] Roth, G.J., Siok, C.J. and Ozols, J. (1980) J. Biol. 
Chem. 255, 1301-1304. 
[21] McMaster, G.K. and Carmichael, G.G. (1977) Proc. Natl. 
Acad. Sci. USA 74, 4835-4838. 
[22] Rollins, T.E. and Smith, W.L. (1980) J. Biol. Chem. 255, 
4872-4875. 
351 
